Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.
Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Continuation Rates | We followed subjects to evaluate the continuation rates for subjects receiving oral contraceptive pills, Depo Provera and Ortho Evra. | 3 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Participants were recruited from a indigent, urban, African American population.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carrie Cwiak, MD, MPH | Emory University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Grady Memorial Hospital | Atlanta | Georgia | 30303 | United States |
All patients were invited to participate.
Participants were recruited from a medical clinic beginning in 10/2004 through 11/2005.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Oral Contraceptive | Participants self-selected to receive oral contraceptives. |
| FG001 | Depo Provera | Participants self-selected to receive Depo Provera |
| FG002 | Ortho Evra | Participants self-selected to receive Ortho Evra. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Oral Contraceptive | Participants self-selected to receive oral contraceptives. |
| BG001 | Depo Provera | Participants self-selected to receive Depo Provera |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Continuation Rates | We followed subjects to evaluate the continuation rates for subjects receiving oral contraceptive pills, Depo Provera and Ortho Evra. | It was a convenience sample. | Posted | Number | participants | 3 months |
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Oral Contraceptives | participants self-selected to take oral contraceptives |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Carrie Cwiak, MD, MPH | Emory University | 404-778-1696 | ccwiak@emory.edu |
Not provided
Not provided
Not provided
Not provided
| BG002 | Ortho Evra | Participants self-selected to receive Ortho Evra. |
| BG003 | Total | Total of all reporting groups |
| Participants |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| The measure is of what contraceptive method the participants chose to use | Number | participants |
|
Participants self-selected to receive Ortho Evra.
|
|
| 0 |
| 111 |
| 0 |
| 111 |
| EG001 | Depo Provera | Participants self-selected to use depo provera | 0 | 109 | 0 | 109 |
| EG002 | Ortho Evra | participants self-selected to receive ortho evra | 0 | 101 | 0 | 101 |
Not provided
Not provided
Not provided